HEALIOS
Healios K.k.
Mark For: HEALIOS™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88015911 |
| Mark Literal Elements | HEALIOS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-09-10 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | M. Scott Alprin |
| Attorney Docket Number | 0078023A |
| Law Office Assigned | M20 |
| Employee Name | FOSDICK, GEOFFREY A |
Timeline
| 2018-06-26 | Application Filed |
| 2019-11-08 | Location: TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED |
| 2019-11-14 | Status: Live/Pending |
| 2019-11-14 | Transaction Date |
| 2020-03-17 | Published |
| 2020-09-10 | Location: INTENT TO USE SECTION |
| 2021-03-17 | Status: A second request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  HEALIOS K.K. |
| Address | 2-4-1 Hamamatsucho Minato-ku, Tokyo JAPAN 105-6115 |
| Legal Entity Type | Kabushiki Kaisha (k.k.) |
| Legal Entity State | JAPAN |
Documents
Drawing
TEAS RF New ApplicationAttorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; biological preparations for veterinary purposes for the treatment of cancer, liver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, liver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; biological preparations for veterinary purposes for the treatment of cancer, liver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, liver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology |
| GS0051 | Cells for medical or clinical use; cells for medical or clinical use for treatment of diseases; stem cells for medical purposes; stem cells for veterinary purposes; surgical implants comprising living tissue grown from stem cells; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for the treatment of ophthalmic, central nervous, respiratory, or cardiovascular disease; biological preparations for veterinary purposes for the treatment of cancer, liver disease and immune system related disease; diagnostic preparations for medical and veterinary use; diagnostic reagents for medicinal use; veterinary diagnostic reagents; adjuvants for medical purposes; cytostatics for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, liver disease and immune system related disease; sanitary preparations for medical use; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for ocular or intraocular surgery; collyrium; eye drops; pharmaceutical agents affecting the central nervous system; pharmaceutical preparations for the peripheral nervous system; cardiovascular agents for medical purposes; cardiovascular treatment preparations; cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; respiratory stimulants; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-inflammatories; pharmaceutical agents affecting digestive organs; pharmaceutical agents for treating physically caused lesions; opotherapy preparations; organotherapy preparations; gene therapy products, namely, genetically engineered tissues for transplant purposes; surgical implants comprised of living tissues; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for use in the fields of anesthesia, oncology, urology and gynecology |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-19 | |
| TEAS EXTENSION RECEIVED | 2021-03-17 | |
| EXTENSION 2 GRANTED | 2021-03-17 | 98765 |
| EXTENSION 2 FILED | 2021-03-17 | 98765 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-09-10 | 65362 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-19 | |
| TEAS EXTENSION RECEIVED | 2020-08-17 | |
| EXTENSION 1 GRANTED | 2020-08-17 | 98765 |
| EXTENSION 1 FILED | 2020-08-17 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-05-12 | |
| PUBLISHED FOR OPPOSITION | 2020-03-17 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-17 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-26 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-13 | |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2020-02-12 | 15911 |
| NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | 2019-11-08 | |
| ACTION DENYING REQ FOR RECON E-MAILED | 2019-11-08 | |
| ACTION CONTINUING FINAL - COMPLETED | 2019-11-08 | 69195 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-30 | 73797 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-30 | 73797 |
| ASSIGNED TO LIE | 2019-10-30 | 73797 |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2019-10-23 | |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2019-10-23 | 15911 |
| EXPARTE APPEAL RECEIVED AT TTAB | 2019-10-23 | |
| EX PARTE APPEAL-INSTITUTED | 2019-10-23 | 15911 |
| NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | 2019-07-17 | |
| ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | 2019-07-17 | 69195 |
| ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | 2019-07-17 | |
| DIVISIONAL PROCESSING COMPLETE | 2019-07-01 | |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-07-01 | 71034 |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2019-04-23 | |
| FINAL REFUSAL WRITTEN | 2019-04-23 | 69195 |
| FINAL REFUSAL E-MAILED | 2019-04-23 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-04-10 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-04-09 | |
| TEAS REQUEST TO DIVIDE RECEIVED | 2019-04-09 | |
| DIVISIONAL REQUEST RECEIVED | 2019-04-09 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-04-09 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-10-16 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-10-16 | 69195 |
| NON-FINAL ACTION E-MAILED | 2018-10-16 | 6325 |
| ASSIGNED TO EXAMINER | 2018-10-16 | 69195 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-07-01 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-06-29 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 